About
The University of Florida College of Veterinary Medicine is currently recruiting dogs with stable congestive heart failure (CHF) and hypochloremia (low blood chloride concentrations) for a clinical trial evaluating the effect of adding acetazolamide to standard-of-care CHF medications on blood chloride levels.
Participation Requirements
Inclusion Criteria: Dogs that weigh more than 4.4 lbs, have stable CHF (not requiring hospitalization), have underlying mitral valve disease and hypochloremia can be considered for enrollment. The dogs must be treated with standard-of-care CHF medications and be willing to eat a diet specifically formulated for heart disease for the study duration (3 months).
Exclusion Criteria: Dogs with normal blood chloride concentrations, advanced kidney disease (serum creatinine >2.5 mg/dl), weight
Owner's Responsibilities
This is a randomized, placebo-controlled study where dogs will receive either treatment with acetazolamide or placebo (suspension without medication in it) twice daily for 2 months. Four visits to UF Cardiology are required. Tests that will be done at these visits include bloodwork, urinalysis, chest xrays and an echocardiogram.
Contact Information
Name: Dr. Adin
Phone: 352 392 2235
Sample Type(s)
Grant ID
Research Program Area
Principal Investigator(s)
Grant Amount
Sponsor(s)